The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF

被引:154
作者
Bi, WZ
Drake, CJ
Schwarz, JJ
机构
[1] Univ Texas, Sch Med, Div Cardiol, Dept Internal Med, Houston, TX 77030 USA
[2] Med Univ S Carolina, Dept Cell Biol & Anat, Cardiovasc Dev Biol Ctr, Charleston, SC 29425 USA
关键词
cardiovascular development; MEF2; angiopoietin; 1; VEGF;
D O I
10.1006/dbio.1999.9307
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The MEF2 family of transcription factors has been implicated in transcriptional regulation in a number of different cell types. Targeted deletion of the MEF2C gene, in particular, revealed its importance for early cardiogenesis (Q. Lin ct al., 1997, Science 276, 1404-1407). We report here that this deletion also resulted in vascular anomalies characterized by extreme variability in lumen size and defects in remodeling. While primary vascular networks formed in the yolk sac of the mutants, they failed to remodel into more complex vascular structures. Likewise, although the primordia of the dorsal aortae formed normally, anomalies were observed in these vessels later in development. Dorsal and anterior to the heart, the aortae exhibited abnormally small lumens, as did the anterior cardinal veins and intersegmental arteries. In contrast, the dorsal aortae and intersegmental arteries caudal to the heart were grossly enlarged. Cranial vessels were also enlarged and less branched than normal. Endocardiogenesis in the mutant was abnormal with the endothelial cells exhibiting a number of aberrant phenotypes. These endocardial defects were accompanied by a notable reduction in angiopoietin 1 and VEGF mRNA production by the myocardium, indicating that MEF2C is required for myocardial expression of these important endothelial-directed cytokines and thus for correct endocardial morphogenesis. (C) 1999 Academic Press.
引用
收藏
页码:255 / 267
页数:13
相关论文
共 53 条
  • [1] Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
    Achen, MG
    Jeltsch, M
    Kukk, E
    Mäkinen, T
    Vitali, A
    Wilks, AF
    Alitalo, K
    Stacker, SA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) : 548 - 553
  • [2] Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal
    Benjamin, LE
    Keshet, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (16) : 8761 - 8766
  • [3] DROSOPHILA MEF2, A TRANSCRIPTION FACTOR THAT IS ESSENTIAL FOR MYOGENESIS
    BOUR, BA
    OBRIEN, MA
    LOCKWOOD, WL
    GOLDSTEIN, ES
    BODMER, R
    TAGHERT, PH
    ABMAYR, SM
    NGUYEN, HT
    [J]. GENES & DEVELOPMENT, 1995, 9 (06) : 730 - 741
  • [4] Role of tissue factor in embryonic blood vessel development
    Carmeliet, P
    Mackman, N
    Moons, L
    Luther, T
    Gressens, P
    VanVlaenderen, I
    Demunck, H
    Kasper, M
    Breier, G
    Evrard, P
    Muller, M
    Risau, W
    Edgington, T
    Collen, D
    [J]. NATURE, 1996, 383 (6595) : 73 - 75
  • [5] Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
    Carmeliet, P
    Ferreira, V
    Breier, G
    Pollefeyt, S
    Kieckens, L
    Gertsenstein, M
    Fahrig, M
    Vandenhoeck, A
    Harpal, K
    Eberhardt, C
    Declercq, C
    Pawling, J
    Moons, L
    Collen, D
    Risau, W
    Nagy, A
    [J]. NATURE, 1996, 380 (6573) : 435 - 439
  • [6] Chen JN, 1996, DEVELOPMENT, V123, P293
  • [7] Choi DS, 1997, DEVELOPMENT, V124, P1745
  • [8] Choi K, 1998, DEVELOPMENT, V125, P725
  • [9] Role of the thrombin receptor In development and evidence for a second receptor
    Connolly, AJ
    Ishihara, H
    Kahn, ML
    Farese, RV
    Coughlin, SR
    [J]. NATURE, 1996, 381 (6582) : 516 - 519
  • [10] DICKSON MC, 1995, DEVELOPMENT, V121, P1845